|
|
|
|
Lonza scientists David Lyon, Ph.D., Molly Adam, and John Baumann discuss emerging strategies for improving the sustainability of spray drying in ASD development. Learn how alternative solvent systems and process aids can address solubility challenges while reducing environmental impact and operational burden.
|
|
|
|
|
Complex storage requirements can result in limited access to vaccines. But what if a formulation that removed the need for cold chain distribution was possible? Learn how dry powder inhalable vaccine formulations may improve shelf stability, simplify distribution, and expand access.
|
|
|
|
|
Advances in spray drying technology are enabling direct-to-lung delivery of therapeutic antibodies, offering a promising approach to improving local treatment and patient outcomes in lung cancer.
|
|
|
|
|
Explore strategies for rapidly developing amorphous solid dispersions that enhance bioavailability, reduce formulation timelines, and help promising drug candidates advance more efficiently.
|
|
|
